Pharmaceuticals | Top 5 Selected Papers in 2024 in the “Pharmacology” Section

1. “Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective”
by David Danielpour
Pharmaceuticals 2024, 17(4), 533; https://doi.org/10.3390/ph17040533
Available online: https://www.mdpi.com/1424-8247/17/4/533

2. “Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database”
by Rosanna Ruggiero, Annamaria Mascolo, Angela Spezzaferri, Claudia Carpentieri, Daniele Torella, Liberata Sportiello, Francesco Rossi, Giuseppe Paolisso and Annalisa Capuano
Pharmaceuticals 2024, 17(2), 147; https://doi.org/10.3390/ph17020147
Available online: https://www.mdpi.com/1424-8247/17/2/147

3. “Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows”
by Maria Chianese, Gianluca Screm, Francesco Salton, Paola Confalonieri, Liliana Trotta, Mariangela Barbieri, Luca Ruggero, Marco Mari, Nicolò Reccardini, Pietro Geri et al.
Pharmaceuticals 2024, 17(6), 709; https://doi.org/10.3390/ph17060709
Available online: https://www.mdpi.com/1424-8247/17/6/709

4. “View on Metformin: Antidiabetic and Pleiotropic Effects, Pharmacokinetics, Side Effects, and Sex-Related Differences”
by Guglielmina Froldi
Pharmaceuticals 2024, 17(4), 478; https://doi.org/10.3390/ph17040478
Available online: https://www.mdpi.com/1424-8247/17/4/478

5. “A Review of Current and Pipeline Drugs for Treatment of Melanoma”
by Nicole Natarelli, Sarah J. Aleman, Isabella M. Mark, Jasmine T. Tran, Sean Kwak, Elizabeth Botto, Shaliz Aflatooni, Michael J. Diaz and Shari R. Lipner
Pharmaceuticals 2024, 17(2), 214; https://doi.org/10.3390/ph17020214
Available online: https://www.mdpi.com/1424-8247/17/2/214